On the public citation graph
Advances in knowledge of inhibitor formation in severe haemophilia A
0 signed · 165 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1002/(issn)2475-0379openalex-snapshot
Research and Practice in Thrombosis and Haemostasis
inferredcites →https://doi.org/10.1002/ajh.23957openalex-snapshot
Impact of inhibitors on hemophilia a mortality in the U nited S tates
inferredcites →https://doi.org/10.1002/elps.201000216openalex-snapshot
Recombinant clotting factor VIII concentrates: Heterogeneity and high‐purity evaluation
inferredcites →https://doi.org/10.1002/hep.22395openalex-snapshot
Mechanism of T cell tolerance induction by murine hepatic Kupffer cells
inferredcites →https://doi.org/10.1002/hep.23191openalex-snapshot
Priming of CD4+ T cells by liver sinusoidal endothelial cells induces CD25low forkhead box protein 3− regulatory T cells suppressing autoimmune hepatitis†
inferredcites →https://doi.org/10.1002/jps.23091openalex-snapshot
Native-Like Aggregates of Factor VIII Are Immunogenic in von Willebrand Factor Deficient and Hemophilia a Mice
inferredcites →https://doi.org/10.1016/j.alit.2017.04.006openalex-snapshot
T follicular helper and TH2 cells in allergic responses
inferredcites →https://doi.org/10.1016/j.biotechadv.2019.06.012openalex-snapshot
Plant cell-made protein antigens for induction of Oral tolerance
inferredcites →https://doi.org/10.1016/j.cell.2016.11.018openalex-snapshot
Gut Microbiota Regulate Motor Deficits and Neuroinflammation in a Model of Parkinson’s Disease
inferredcites →https://doi.org/10.1016/j.cellimm.2015.10.001openalex-snapshot
In vivo induction of regulatory T cells for immune tolerance in hemophilia
inferredcites →https://doi.org/10.1016/j.cellimm.2015.11.001openalex-snapshot
Hunting down factor VIII in the immunopeptidome
inferredcites →https://doi.org/10.1016/j.cellimm.2015.11.004openalex-snapshot
Tolerogenic nanoparticles to induce immunologic tolerance: Prevention and reversal of FVIII inhibitor formation
inferredcites →https://doi.org/10.1016/j.cellimm.2016.01.003openalex-snapshot
B-cell memory against factor VIII
inferredcites →https://doi.org/10.1016/j.cyto.2012.03.018openalex-snapshot
Th17 cell-derived IL-17 is dispensable for B cell antibody production
inferredcites →https://doi.org/10.1016/j.ijpharm.2018.07.018openalex-snapshot
Subcutaneous administration of Lyso-phosphatidylserine nanoparticles induces immunological tolerance towards Factor VIII in a Hemophilia A mouse model
inferredcites →https://doi.org/10.1016/j.immuni.2005.04.004openalex-snapshot
Dynamics and Function of Langerhans Cells In Vivo
inferredcites →https://doi.org/10.1016/j.immuni.2013.08.003openalex-snapshot
Tryptophan Catabolites from Microbiota Engage Aryl Hydrocarbon Receptor and Balance Mucosal Reactivity via Interleukin-22
inferredcites →https://doi.org/10.1016/j.immuni.2015.04.005openalex-snapshot
Regulatory B Cells: Origin, Phenotype, and Function
inferredcites →https://doi.org/10.1016/j.immuni.2017.04.008openalex-snapshot
Homeostatic Immunity and the Microbiota
inferredcites →https://doi.org/10.1016/j.intimp.2014.03.010openalex-snapshot
IL-17 promotes Type 1 T cell response through modulating dendritic cell function in acute allograft rejection
inferredcites →https://doi.org/10.1016/j.it.2006.12.006openalex-snapshot
Opposing effects of Toll-like receptor stimulation induce autoimmunity or tolerance
inferredcites →https://doi.org/10.1016/j.it.2015.12.005openalex-snapshot
Re-examining the Nature and Function of Self-Reactive T cells
inferredcites →https://doi.org/10.1016/j.jaci.2011.08.029openalex-snapshot
Uptake of blood coagulation factor VIII by dendritic cells is mediated via its C1 domain
inferredcites →https://doi.org/10.1016/j.jaci.2016.03.057openalex-snapshot
Epicutaneous immunotherapy induces gastrointestinal LAP+ regulatory T cells and prevents food-induced anaphylaxis
inferredcites →https://doi.org/10.1016/j.jhep.2015.01.006openalex-snapshot
Nanoparticle-based autoantigen delivery to Treg-inducing liver sinusoidal endothelial cells enables control of autoimmunity in mice
inferredcites →https://doi.org/10.1016/j.thromres.2018.05.027openalex-snapshot
Risk factors for inhibitor development in severe hemophilia A
inferredcites →https://doi.org/10.1016/j.xphs.2018.08.022openalex-snapshot
Effects of Product Handling Parameters on Particle Levels in a Commercial Factor VIII Product: Impacts and Mitigation
inferredcites →https://doi.org/10.1016/s0021-9258(18)52225-0openalex-snapshot
von Willebrand factor mediates protection of factor VIII from activated protein C-catalyzed inactivation
inferredcites →https://doi.org/10.1021/ac970372zopenalex-snapshot
Structural Characterization of Site-Specific N-Glycosylation of Recombinant Human Factor VIII by Reversed-Phase High-Performance Liquid Chromatography−Electrospray Ionization Mass Spectrometry
inferredcites →https://doi.org/10.1038/gt.2009.13openalex-snapshot
Indoleamine 2,3-dioxygenase attenuates inhibitor development in gene-therapy-treated hemophilia A mice
inferredcites →https://doi.org/10.1038/mt.2011.134openalex-snapshot
Suppression of the Immune Response to FVIII in Hemophilia A Mice by Transgene Modified Tolerogenic Dendritic Cells
inferredcites →https://doi.org/10.1038/nature11053openalex-snapshot
Human gut microbiome viewed across age and geography
inferredcites →https://doi.org/10.1038/nature12726openalex-snapshot
Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation
inferredcites →https://doi.org/10.1038/ni.1817openalex-snapshot
Mechanisms maintaining peripheral tolerance
inferredcites →https://doi.org/10.1038/ni.2939openalex-snapshot
Type I and type II Fc receptors regulate innate and adaptive immunity
inferredcites →https://doi.org/10.1038/ni.3713openalex-snapshot
Gut microbial metabolites limit the frequency of autoimmune T cells and protect against type 1 diabetes
inferredcites →https://doi.org/10.1038/ni1552openalex-snapshot
Interleukin 17–producing T helper cells and interleukin 17 orchestrate autoreactive germinal center development in autoimmune BXD2 mice
inferredcites →https://doi.org/10.1038/nm.3554openalex-snapshot
Interleukin-35 induces regulatory B cells that suppress autoimmune disease
inferredcites →https://doi.org/10.1038/nri1457openalex-snapshot
Ido expression by dendritic cells: tolerance and tryptophan catabolism
inferredcites →https://doi.org/10.1038/nri3383openalex-snapshot
Marginal zone B cells: virtues of innate-like antibody-producing lymphocytes
inferredcites →https://doi.org/10.1038/nri3521openalex-snapshot
The speed of change: towards a discontinuity theory of immunity?
inferredcites →https://doi.org/10.1046/j.1365-2516.2003.00780.xopenalex-snapshot
The epidemiology of inhibitors in haemophilia A: a systematic review
inferredcites →https://doi.org/10.1046/j.1538-7836.2003.00366.xopenalex-snapshot
Recognition of coagulation factor VIII by CD4+ T cells of healthy humans
inferredcites →https://doi.org/10.1055/s-0038-1651565openalex-snapshot
A Higher than Expected Incidence of Factor VIII Inhibitors in Multitransfused Haemophilia A Patients Treated with an Intermediate Purity Pasteurized Factor VIII Concentrate
inferredcites →https://doi.org/10.1055/s-0039-1688413openalex-snapshot
Molecular Aggregation of Marketed Recombinant FVIII Products: Biochemical Evidence and Functional Effects
inferredcites →https://doi.org/10.1056/nejmoa075760openalex-snapshot
Inhibitors of Factor VIII in Black Patients with Hemophilia
inferredcites →https://doi.org/10.1056/nejmoa1516437openalex-snapshot
A Randomized Trial of Factor VIII and Neutralizing Antibodies in Hemophilia A
inferredcites →https://doi.org/10.1056/nejmoa1708483openalex-snapshot
AAV5–Factor VIII Gene Transfer in Severe Hemophilia A
inferredcites →https://doi.org/10.1073/pnas.0702120104openalex-snapshot
A role for exposed mannosylations in presentation of human therapeutic self-proteins to CD4+ T lymphocytes
inferredcites →https://doi.org/10.1073/pnas.82.24.8752openalex-snapshot
Purified human factor VIII procoagulant protein: comparative hemostatic response after infusions into hemophilic and von Willebrand disease dogs.
inferredcites →https://doi.org/10.1074/jbc.274.53.37685openalex-snapshot
Role of the Low Density Lipoprotein-related Protein Receptor in Mediation of Factor VIII Catabolism
inferredcites →https://doi.org/10.1074/jbc.m008046200openalex-snapshot
Cell Surface Heparan Sulfate Proteoglycans Participate in Factor VIII Catabolism Mediated by Low Density Lipoprotein Receptor-related Protein
inferredcites →https://doi.org/10.1080/17474086.2019.1604213openalex-snapshot
An update on the ‘danger theory’ in inhibitor development in hemophilia A
inferredcites →https://doi.org/10.1084/jem.20160789openalex-snapshot
The aryl hydrocarbon receptor controls cell-fate decisions in B cells
inferredcites →https://doi.org/10.1093/intimm/dxh142openalex-snapshot
Marginal zone B cells transport and deposit IgM-containing immune complexes onto follicular dendritic cells
inferredcites →https://doi.org/10.1111/(issn)1538-7836openalex-snapshot
Journal of Thrombosis and Haemostasis
inferredcites →https://doi.org/10.1111/1471-0528.13601openalex-snapshot
Impact of maternal intrapartum antibiotics, method of birth and breastfeeding on gut microbiota during the first year of life: a prospective cohort study
inferredcites →https://doi.org/10.1111/ajt.15546openalex-snapshot
Antigen-dependent interactions between regulatory B cells and T cells at the T:B border inhibit subsequent T cell interactions with DCs
inferredcites →https://doi.org/10.1111/hae.13740openalex-snapshot
The national blueprint for future basic and translational research to understand factor VIII immunogenicity: NHLBI State of the Science Workshop on factor VIII inhibitors
inferredcites →https://doi.org/10.1111/hae.13747openalex-snapshot
Recombinant factor VIII products and inhibitor development in previously untreated patients with severe haemophilia A: Combined analysis of three studies
inferredcites →https://doi.org/10.1111/j.1365-2141.2005.05605.xopenalex-snapshot
Environmental risk factors for inhibitor development in children with haemophilia A: a case–control study
inferredcites →https://doi.org/10.1111/j.1365-2516.2011.02679.xopenalex-snapshot
Immunoprotective effect of von Willebrand factor towards therapeutic factor VIII in experimental haemophilia A
inferredcites →https://doi.org/10.1111/j.1538-7836.2005.01389.xopenalex-snapshot
The B domain of coagulation factor VIII interacts with the asialoglycoprotein receptor
inferredcites →https://doi.org/10.1111/j.1538-7836.2006.02118.xopenalex-snapshot
Induction of partial immune tolerance to factor VIII through prior mucosal exposure to the factor VIII C2 domain
inferredcites →https://doi.org/10.1111/j.1538-7836.2008.03165.xopenalex-snapshot
Reduction of the immune response to factor VIII mediated through tolerogenic factor VIII presentation by immature dendritic cells
inferredcites →https://doi.org/10.1111/j.1538-7836.2009.03314.xopenalex-snapshot
Induction of factor VIII-specific unresponsiveness by intrathymic factor VIII injection in murine hemophilia A
inferredcites →https://doi.org/10.1111/j.1538-7836.2009.03571.xopenalex-snapshot
Splenic marginal zone antigen‐presenting cells are critical for the primary allo‐immune response to therapeutic factor VIII in hemophilia A
inferredcites →https://doi.org/10.1111/j.1538-7836.2011.04472.xopenalex-snapshot
Can B‐domain deletion alter the immunogenicity of recombinant factor VIII? A meta‐analysis of prospective clinical studies
inferredcites →https://doi.org/10.1111/j.1749-6632.2009.05137.xopenalex-snapshot
B10 cells and regulatory B cells balance immune responses during inflammation, autoimmunity, and cancer
inferredcites →https://doi.org/10.1111/j.1753-4887.1981.tb06752.xopenalex-snapshot
Proceedings of the National Academy of Sciences of the United States of America
inferredcites →https://doi.org/10.1111/jth.13570openalex-snapshot
Enhanced uptake of blood coagulation factor VIII containing immune complexes by antigen presenting cells
inferredcites →https://doi.org/10.1111/jth.13917openalex-snapshot
Identification of aggregates in therapeutic formulations of recombinant full‐length factor VIII products by sedimentation velocity analytical ultracentrifugation
inferredcites →https://doi.org/10.1111/jth.13936openalex-snapshot
Early cellular interactions and immune transcriptome profiles in human factor VIII‐exposed hemophilia A mice
inferredcites →https://doi.org/10.1111/jth.14204openalex-snapshot
In‐depth comparison of N‐glycosylation of human plasma‐derived factor VIII and different recombinant products: from structure to clinical implications
inferredcites →https://doi.org/10.1111/jth.14404openalex-snapshot
The endothelial lectin clearance receptor CLEC4M binds and internalizes factor VIII in a VWF‐dependent and independent manner
inferredcites →https://doi.org/10.1111/jth.14521openalex-snapshot
The scavenger receptor SCARA5 is an endocytic receptor for von Willebrand factor expressed by littoral cells in the human spleen
inferredcites →https://doi.org/10.1111/jth.14660openalex-snapshot
Pharmacokinetics, immunogenicity, safety, and preliminary efficacy of subcutaneous turoctocog alfa pegol in previously treated patients with severe hemophilia A (alleviate 1)
inferredcites →https://doi.org/10.1111/pbi.12859openalex-snapshot
Expression and assembly of largest foreign protein in chloroplasts: oral delivery of human FVIII made in lettuce chloroplasts robustly suppresses inhibitor formation in haemophilia A mice
inferredcites →https://doi.org/10.1126/science.1108003openalex-snapshot
Differential Lysosomal Proteolysis in Antigen-Presenting Cells Determines Antigen Fate
inferredcites →https://doi.org/10.1126/science.1178334openalex-snapshot
Mechanisms Underlying Lineage Commitment and Plasticity of Helper CD4 + T Cells
inferredcites →https://doi.org/10.1126/science.1237439openalex-snapshot
The Long-Term Stability of the Human Gut Microbiota
inferredcites →https://doi.org/10.1126/science.3107127openalex-snapshot
Interferon-γ and B Cell Stimulatory Factor-1 Reciprocally Regulate Ig Isotype Production
inferredcites →https://doi.org/10.1126/scitranslmed.aad7121openalex-snapshot
Antibiotics, birth mode, and diet shape microbiome maturation during early life
inferredcites →https://doi.org/10.1146/annurev.iy.12.040194.005015openalex-snapshot
Tolerance, Danger, and the Extended Family
inferredcites →https://doi.org/10.1155/2013/793502openalex-snapshot
Detection of Intracellular Factor VIII Protein in Peripheral Blood Mononuclear Cells by Flow Cytometry
inferredcites →https://doi.org/10.1160/th06-09-0519openalex-snapshot
Cytokine production by CD4+ T cells specific for coagulation factor VIII in healthy subjects and haemophilia A patients
inferredcites →https://doi.org/10.1172/jci65260openalex-snapshot
Specialized role of migratory dendritic cells in peripheral tolerance induction
inferredcites →https://doi.org/10.1172/jci73316openalex-snapshot
Emerging roles of lymphatic endothelium in regulating adaptive immunity
inferredcites →https://doi.org/10.1172/jci81859openalex-snapshot
IDO1 suppresses inhibitor development in hemophilia A treated with factor VIII
inferredcites →https://doi.org/10.1172/jci96400openalex-snapshot
The endothelial cell receptor stabilin-2 regulates VWF-FVIII complex half-life and immunogenicity
inferredcites →https://doi.org/10.1182/blood-2006-06-026104openalex-snapshot
A sequence variation scan of the coagulation factor VIII (FVIII) structural gene and associations with plasma FVIII activity levels
inferredcites →https://doi.org/10.1182/blood-2008-01-133181openalex-snapshot
Macrophages contribute to the cellular uptake of von Willebrand factor and factor VIII in vivo
inferredcites →https://doi.org/10.1182/blood-2009-01-200725openalex-snapshot
Lineages of human T-cell clones, including T helper 17/T helper 1 cells, isolated at different stages of anti–factor VIII immune responses
inferredcites →https://doi.org/10.1182/blood-2011-09-379453openalex-snapshot
F8 gene mutation type and inhibitor development in patients with severe hemophilia A: systematic review and meta-analysis
inferredcites →https://doi.org/10.1182/blood-2012-07-444877openalex-snapshot
Distinct characteristics of antibody responses against factor VIII in healthy individuals and in different cohorts of hemophilia A patients
inferredcites →https://doi.org/10.1182/blood-2012-09-457036openalex-snapshot
Intensity of factor VIII treatment and inhibitor development in children with severe hemophilia A: the RODIN study
inferredcites →https://doi.org/10.1182/blood-2014-09-598268openalex-snapshot
Affinity of FVIII-specific antibodies reveals major differences between neutralizing and nonneutralizing antibodies in humans
inferredcites →https://doi.org/10.1182/blood-2014-09-599365openalex-snapshot
Factor VIII gene variants and inhibitor risk in African American hemophilia A patients
inferredcites →https://doi.org/10.1182/blood-2015-12-684688openalex-snapshot
Patterns of expression of factor VIII and von Willebrand factor by endothelial cell subsets in vivo
inferredcites →https://doi.org/10.1182/blood-2016-06-720086openalex-snapshot
Nonneutralizing antibodies against factor VIII and risk of inhibitor development in severe hemophilia A
inferredcites →https://doi.org/10.1182/blood-2018-01-829523openalex-snapshot
A factor VIII–nanobody fusion protein forming an ultrastable complex with VWF: effect on clearance and antibody formation
inferredcites →https://doi.org/10.1182/blood.2019000658openalex-snapshot
Timing of inhibitor development in more than 1000 previously untreated patients with severe hemophilia A
inferredcites →https://doi.org/10.1182/blood.v95.11.3435openalex-snapshot
Antibodies to the FVIII light chain that neutralize FVIII procoagulant activity are present in plasma of nonresponder patients with severe hemophilia A and in normal polyclonal human IgG
inferredcites →https://doi.org/10.1182/bloodadvances.2017008706openalex-snapshot
CD4 T cells specific for factor VIII are present at high frequency in healthy donors and comprise naïve and memory cells
inferredcites →https://doi.org/10.1182/bloodadvances.2018027979openalex-snapshot
FVIII expression by its native promoter sustains long-term correction avoiding immune response in hemophilic mice
inferredcites →https://doi.org/10.1182/bloodadvances.2018030452openalex-snapshot
Peptides identified on monocyte-derived dendritic cells: a marker for clinical immunogenicity to FVIII products
inferredcites →https://doi.org/10.1186/s13023-018-0929-9openalex-snapshot
Inhibitor clinical burden of disease: a comparative analysis of the CHESS data
inferredcites →https://doi.org/10.1208/s12248-009-9119-yopenalex-snapshot
Role of Glycosylation in Conformational Stability, Activity, Macromolecular Interaction and Immunogenicity of Recombinant Human Factor VIII
inferredcites →https://doi.org/10.1208/s12248-019-0336-8openalex-snapshot
Fc-Fusion Drugs Have FcγR/C1q Binding and Signaling Properties That May Affect Their Immunogenicity
inferredcites →https://doi.org/10.1371/journal.pone.0080239openalex-snapshot
Limited Promiscuity of HLA-DRB1 Presented Peptides Derived of Blood Coagulation Factor VIII
inferredcites →https://doi.org/10.3324/haematol.2015.137067openalex-snapshot
von Willebrand factor binds to the surface of dendritic cells and modulates peptide presentation of factor VIII
inferredcites →https://doi.org/10.3324/haematol.2016.148502openalex-snapshot
The C1 and C2 domains of blood coagulation factor VIII mediate its endocytosis by dendritic cells
inferredcites →https://doi.org/10.3324/haematol.2017.165720openalex-snapshot
Complement C3 is a novel modulator of the anti-factor VIII immune response
inferredcites →https://doi.org/10.3324/haematol.2018.188219openalex-snapshot
N-linked glycosylation modulates the immunogenicity of recombinant human factor VIII in hemophilia A mice
inferredcites →https://doi.org/10.3324/haematol.2018.189852openalex-snapshot
Dexamethasone promotes durable factor VIII-specific tolerance in hemophilia A mice via thymic mechanisms
inferredcites →https://doi.org/10.3324/haematol.2018.200279openalex-snapshot
Prevention of the anti-factor VIII memory B-cell response by inhibition of Bruton tyrosine kinase in experimental hemophilia A
inferredcites →https://doi.org/10.3324/haematol.2018.206383openalex-snapshot
Pathogenic immune response to therapeutic factor VIII: exacerbated response or failed induction of tolerance?
inferredcites →https://doi.org/10.3324/haematol.2018.212001openalex-snapshot
Role of factor VIII-binding capacity of endogenous von Willebrand factor in the development of factor VIII inhibitors in patients with severe hemophilia A
inferredcites →https://doi.org/10.3389/fimmu.2012.00305openalex-snapshot
Lymphatic endothelial cells - key players in regulation of tolerance and immunity
inferredcites →https://doi.org/10.4049/jimmunol.0803404openalex-snapshot
Human Liver Dendritic Cells Promote T Cell Hyporesponsiveness
inferredcites →https://doi.org/10.4049/jimmunol.0901884openalex-snapshot
Langerhans Cells Suppress Contact Hypersensitivity Responses Via Cognate CD4 Interaction and Langerhans Cell-Derived IL-10
inferredcites →https://doi.org/10.4049/jimmunol.178.10.6217openalex-snapshot
Fcγ Receptor IIB on Dendritic Cells Enforces Peripheral Tolerance by Inhibiting Effector T Cell Responses
inferredcites →https://doi.org/10.4159/harvard.9780674731370openalex-snapshot
The Integrity of the Body
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.2139/ssrn.4789895openalex-extracted
Maternal Microchimerism Promotes Tolerance Induction Toward Factor VIII in Severe Haemophilia a Children with Inhibitors
inferred← citeshttps://doi.org/10.1002/eji.202350807openalex-snapshot
Elevated memory T‐cell conversion in a preclinical mouse model of hemophilia A
inferred← citeshttps://doi.org/10.1002/hsr2.71331openalex-snapshot
Immune System‐Related Genetic Risk Factors for Inhibitory Antibody Development in Patients With Hemophilia: Reviewing an Old Problem From a New Perspective—A Narrative Review
inferred← citeshttps://doi.org/10.1007/978-3-031-38058-7_4openalex-snapshot
Serious Blood Disorders: A Focus on Sickle Cell Disease and Hemophilia
inferred← citeshttps://doi.org/10.1016/j.isci.2026.114924openalex-snapshot
A combinatorial CAAR-T cell strategy to eliminate factor VIII inhibitors in preclinical models of hemophilia A
inferred← citeshttps://doi.org/10.1016/j.jtha.2023.08.033openalex-snapshot
Mice possess a more limited natural antihuman factor VIII antibody repertoire than humans that is produced disproportionately by marginal zone B cells
inferred← citeshttps://doi.org/10.1016/j.jtha.2025.04.015openalex-snapshot
Outcomes of immune tolerance induction with rituximab to eradicate high-titer inhibitor of hemophilia A: depicted by exponential decay model and the gene expression profile of different outcomes by RNA-sequencing
inferred← citeshttps://doi.org/10.1016/j.omtm.2021.10.015openalex-snapshot
Efficient and safe correction of hemophilia A by lentiviral vector-transduced BOECs in an implantable device
inferred← citeshttps://doi.org/10.1016/j.rpth.2025.102858openalex-snapshot
Effect of DNA methylation on inhibitor development in people with hemophilia A treated with FVIII concentrates
inferred← citeshttps://doi.org/10.1038/s41435-025-00325-7openalex-snapshot
A scan of pleiotropic immune mediated disease genes identifies novel determinants of baseline FVIII inhibitor status in hemophilia A
inferred← citeshttps://doi.org/10.1053/j.jvca.2020.06.074openalex-snapshot
Perioperative Management of Hemophilia A Patients Undergoing Cardiac Surgery: A Literature Review of Published Cases
inferred← citeshttps://doi.org/10.1055/a-1665-6232openalex-snapshot
An Update on Laboratory Diagnostics in Haemophilia A and B
inferred← citeshttps://doi.org/10.1055/a-2687-0107openalex-snapshot
Laboratory Monitoring in Patients Receiving Emicizumab
inferred← citeshttps://doi.org/10.1055/s-0040-1712157openalex-snapshot
Passive Immunity for Coronavirus Disease 2019: A Commentary on Therapeutic Aspects Including Convalescent Plasma
inferred← citeshttps://doi.org/10.1080/09593985.2022.2070886openalex-snapshot
Strength training program for an athlete with hemophilia A and an inhibitor while taking a new prophylactic drug treatment: a case report
inferred← citeshttps://doi.org/10.1089/hum.2021.145openalex-snapshot
Modulation of Immune Reaction in Hydrodynamic Gene Therapy for Hemophilia A
inferred← citeshttps://doi.org/10.1111/hae.14589openalex-snapshot
Plasma‐derived FVIII/VWF complex shows higher protection against inhibitors than isolated FVIII after infusion in haemophilic patients: A translational study
inferred← citeshttps://doi.org/10.1111/hae.14857openalex-snapshot
Evaluation of the care pathway in the context of the dispensing of emicizumab (Hemlibra) in community and hospital pharmacies in France: A patient satisfaction survey
inferred← citeshttps://doi.org/10.1111/hae.15005openalex-snapshot
Dental management of people with complex or rare inherited bleeding disorders
inferred← citeshttps://doi.org/10.1177/10760296231167416openalex-snapshot
Occurrence of FVIII Inhibitors in Hemophilia A Patients Following an Institutional Switch to a Third Generation B-Domain-Deleted FVIII
inferred← citeshttps://doi.org/10.1177/2058738420934618openalex-snapshot
A previously treated severe haemophilia A patient developed high-titre inhibitor after vaccinations
inferred← citeshttps://doi.org/10.1182/blood.2021012121openalex-snapshot
Nonhuman sugars cause factor VIII troubles
inferred← citeshttps://doi.org/10.1182/blood.2023020005openalex-snapshot
Safety and efficacy of an anti–human APC antibody for prophylaxis of congenital factor deficiencies in preclinical models
inferred← citeshttps://doi.org/10.1182/blood.2025029470openalex-snapshot
The T follicular helper/T follicular helper regulatory pathway in FVIII immune responses in mice
inferred← citeshttps://doi.org/10.1182/bloodadvances.2021006359openalex-snapshot
Pharmacokinetic analysis identifies a factor VIII immunogenicity threshold after AAV gene therapy in hemophilia A mice
inferred← citeshttps://doi.org/10.1182/bloodadvances.2023011388openalex-snapshot
Predicting inhibitor development using a random peptide phage-display library approach in the SIPPET cohort
inferred← citeshttps://doi.org/10.1186/s13023-023-02654-0openalex-snapshot
Assessing the value of bypassing agent therapy used prophylactic versus on-demand, during immune tolerance induction for treatment of inhibitors: a retrospective chart review
inferred← citeshttps://doi.org/10.1371/journal.pone.0233576openalex-snapshot
Comparative glycosylation mapping of plasma-derived and recombinant human factor VIII
inferred← citeshttps://doi.org/10.2147/pgpm.s383221openalex-snapshot
Current Understanding of Inherited Modifiers of FVIII Pharmacokinetic Variation
inferred← citeshttps://doi.org/10.22099/mbrc.2021.39067.1573openalex-snapshot
Experimental validation of a predicted microRNA within human FVIII gene.
inferred← citeshttps://doi.org/10.23736/s1824-4785.22.03474-4openalex-snapshot
The value of radiosynoviorthesis for treatment of chronic synovitis in hemophilic joint disease
inferred← citeshttps://doi.org/10.30895/2221-996x-2021-21-2-97-107openalex-snapshot
Factor VIII products: key aspects of development, clinical research and use (part 2)
inferred← citeshttps://doi.org/10.3324/haematol.2021.278579openalex-snapshot
Non-inhibitory antibodies inducing increased emicizumab clearance in a severe haemophilia A inhibitor patient
inferred← citeshttps://doi.org/10.3389/fgene.2025.1506862openalex-snapshot
Disentangling effects of the DR and DQ isomers encoded by the HLA class II haplotype DRB1*15:01/DQB1*06:02 to help establish the true risk allele for FVIII inhibitor development in Hemophilia A
inferred← citeshttps://doi.org/10.3389/fimmu.2022.1070476openalex-snapshot
Autologous bone marrow-derived MSCs engineered to express oFVIII-FLAG engraft in adult sheep and produce an effective increase in plasma FVIII levels
inferred← citeshttps://doi.org/10.3389/fimmu.2023.1275193openalex-snapshot
Antigen-dependent modulation of immune responses to antigen-Fc fusion proteins by Fc-effector functions
inferred← citeshttps://doi.org/10.3389/fimmu.2025.1716950openalex-snapshot
Transplanted gene-modified placental cells boost FVIII activity in pediatric sheep without eliciting immunity, toxicity, or adverse events
inferred← citeshttps://doi.org/10.3389/fimmu.2026.1921432openalex-snapshot
Maternal microchimerism accelerates immune tolerance induction to factor VIII in children with hemophilia A and FVIII inhibitors
inferred← citeshttps://doi.org/10.3390/life14081041openalex-snapshot
Comprehensive Screening of Genetic Variants in the Coding Region of F8 in Severe Hemophilia A Reveals a Relationship with Disease Severity in a Colombian Cohort
inferred← citeshttps://doi.org/10.47489/szmc.v37i4.403openalex-snapshot
Development Of Inhibitors In Hemophilia A Patients Receiving Different Treatment Options
inferred← citeshttps://doi.org/10.9734/ibrr/2023/v14i4324openalex-snapshot
Systematic Review of Genetic-Related Risk Factor and Inhibitor Epidemiology in People with Severe Hemophilia a from Africa: A 2023 Update
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.